Pharmacokinetics of disodium-fosfomycin in mongrel dogs

Research in Veterinary Science

Volumn 85, Issue 1, 2008, Pages 156-161

  Gutierrez, O L ^a   Ocampo, C L ^a   Aguilera, J R ^a   Luna, J ^a   Sumano, L H ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Dogs; Fosfomycin; Kidney; Pharmacokinetics

Indexed keywords

FOSFOMYCIN SODIUM;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BACTERIUM; BIOCHEMISTRY; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN BINDING;

CANIS FAMILIARIS;

EID: 43849110770     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.08.011     Document Type: Article

References (36)

1. J.M. Andrews F. Baquero J.M. Beltran E. Canton F. Crokaert M. Gobernado R. Gomez-lus E. Loza M. Navarro T. Olay A. Rodriguez M.V. Vicente R. Wise E. Yourassowsky International collaborative study on standardization of bacterial sensitivity to fosfomycin Journal of Antimicrobial Chemotherapy 12 1983 357 361
2. J. Aramayona M. Bregante C. Solans S. Rueda L.J. Fraile M.A. García Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration Veterinary Research 28 1997 581 588
3. J.B. Bennet J. Brodie E. Benner W. Kirby Simplified accurate method for antibiotic assay. Clinical Specimens American Society for Microbiology 14 1966 170 177
4. T. Bergan Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives Chemotherapy 36 1990 10 18
5. ®) bioavailabity and feed-drug interaction European Urology 13 1987 64 68
6. F. Borsa A. Leroy J. Fillastre M. Godin B. Moulin Comparative pharmacokinetics of trometamol-fosfomycin and calcium-fosfomycin in young and elderly adults Antimicrobial Agents and Chemotherapy 32 1988 938 941
7. M. Cree S. Stacey N. Graham C. Wainwright Fosfomycin – investigation of a possible new rout of administration of an old drug A case study Journal of Cystic Fibrosis 6 2007 244 246
8. E. Faragó I.J. Kiss Z. Nábrádi Serum and lung tissue levels of fosfomycin in humans International Journal of Clinical Pharmacology and Therapy and Toxicology 18 1980 554 558
9. L. Fernández E. Mariño A. Dominguez-Gil Phosphomycin levels in plasma and interstitial tissue fluid in a multiple dosage regimen in rabbits Arzneimittel-Forschung 37 1987 927 929
10. P. Fernández I. Herrera P. Martinez L. Gómez J. Prieto Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents Chemotheraphy 41 1995 45 49
11. A. Fernández R. Payuelo J. Gómez J. Ramos A. Loste M. Marca Efficacy of phosphomycin in the control of Escherichia coli infection of broiler chickens Research in Veterinary Science 65 1998 201 204
12. A. Fernández C. Lara A. Loste S. Calvo M. Marca Control of Salmonella enteritidis phage type 4 experimental infection by fosfomycin in newly hatched chicks Comparative Immunology, Microbiology and Infectious Diseases 24 2001 207 216
13. A. Fernández C. Lara A. Loste M. Marca Efficacy of calcium-fosfomycin for the treatment of experimental infections of broiler chickens with Escherichia coli 078: k80 Veterinary Research Communications 26 2002 427 436
14. M. Gobernado Fosfomicina Revista Espanola de Quimioterapia 16 2003 15 40
15. K. Grif M. Dierich K. Pfaller P. Miglioli F. Allerberger In vitro activity of fosfomycin in combination with various antistaphylococcal substances The Journal of Antimicrobial Chemotherapy 48 2001 209 217
16. J.M. Hamilton-Miller In vitro activity of fosfomycin against’problem’ gram-positive cocci Microbios 71 1992 95 103
17. E. Hernández A. Loste M. Bregante M. Garcı´a C. Solans Determination of fosfomycin in chicken plasma samples by gas chromatography: application to pharmacokinetic studies Chromatographia 54 2001 365 368
18. T. Ishizawa S. Sadahiro K. Hosoi I. Tamai T. Terasaki A. Tsuji Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans Journal of Pharmacobio-Dynamics 9 1992 481 489
19. C. Joukhadar N. Klein P. Dittrich M. Zeitlinger A. Geppert K. Skhirtladze Target site penetration of fosfomycin in critically ill patients The Journal of Antimicrobial Chemotherapy 51 2003 1247 1252
20. R. Krause S. Patruta F. Daxböck P. Fladerer C. Wenisch The Effect of fosfomycin on neutrophil function The Journal of Antimicrobial Chemotherapy 47 2001 141 146
21. T. Matsumoto K. Tateda S. Miyakasi N. Furuya Inmunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomona aeruginosa in mice Antimicrobial Agents and Chemotherapy 41 1997 308 313
22. T. Nakamara I. Hashimoto Y. Sawada J. Mikami E. Bekki Clinical studies on fosfomycin sodium following intravenous administration Japanese Journal of Antibiotics 38 1985 2057 2067
23. M. Paape R. Miller G. Ziv Pharmacology enhancement or suppression of phagocytosis by bovine neutrophils American Journal of Veterinary Research 52 1991 363 366
24. S. Patel J. Balfour H. Bryson Fosfomycin trometamol. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections Drugs 53 1997 637 656
25. P. Pérez-Fernández I. Herrera M.L. Gómez-Lus J. Prieto Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents Chemotherapy 41 1995 45 49
26. J.A. Pickrell Ototoxicity in dogs and cats Seminars in Veterinary Medicine and Surgery (Small Animal) 8 1993 42 49
27. J. Prescott Prescott, J.F. (2000) Peptide antibiotics: polymixins, glycopeptides, streptogramins and bacitracin J. Prescott D. Baggot R. Walter Antimicrobial therapy in veterinary medicine third ed. 2000 Iowa State University Press Ames IS 190
28. H. Pullukcu M. Tasbakan O.R. Sipahi T. Yamazhan S. Aydemir S. Ulusoy Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections International Journal of Antimicrobial Agents 29 2007 62 65
29. G. Segre E. Bianchi A. Cataldi G. Zannini Pharmacokinetic profile of fosfomycin trometamol European Urology 13 1987 56 63
30. S.M. Singhvi A.F. Heald H.H. Gadebusch M.E. Resnick L.T. Ditazio M.A. Leitz Human serum protein binding of cephalosporin antibiotics in vitro Journal of Laboratory and Clinical Medicine 89 1977 414 420
31. J.P. Stahl Diffusion de la fosfomycine dans le liquide céphalo-rachidien au cours des méningites purulentes Presse Médicale 13 1984 2693 2695
32. J.P. Stahl Traitement des méningites bactériennes neurochirurgicales par l’association ceftriaxone-fosfomycine Pathologie-Biologie 34 1986 479 482
33. L.H. Sumano C.L. Ocampo O.L. Gutierrez Intravenous and intramuscular pharmacokinetics of a single-daily dose of disodium–fosfomycin in cattle, administered for 3 days Journal of Veterinary Pharmacology and Therapeutics 30 2007 49 54
34. I. Tamai A. Tsuji Carrier-mediated approaches for oral drug delivery Advanced Drug Delivery Reviews 20 1996 5 32
35. F. Tessier C. Quentin In vitro activity of fosfomycin combined with ceftazidine, imipem, amikacin and ciprofloxacin against Pseudomona aeruginosa Clinical Microbiology and Infection 16 1997 159 162
36. M. Zeitlinger R. Sauermann F. Traunmüller A. Georgopoulos M. Müller C. Joukhadar Impact of plasma protein binding on antimicrobial activity using time-killing curves The Journal of Antimicrobial Chemotherapy 54 2004 876 880